Elixinol CEO offers insight into Europe strategy, supply-chain restructuring

This is the second part of an interview with Elixinol CEO Oliver Horn. Read his insights on leadership here. In a recent presentation, you said the company was “well-positioned to navigate the regulatory environment that is dynamic, and we remain very positive that regulatory changes are working in our favor.” What makes Elixinol well-positioned to […]

Canadian labeling, potency lawsuit includes CBD products

A CBD maker is among more than a dozen Canadian cannabis companies facing a labeling lawsuit. The lawsuit, filed in Alberta by consumer Lisa Marie Langevin, accuses the companies and their subsidiaries of selling products “with THC or CBD content levels that were drastically different” from what was advertised. Canada allows 15% variance for most […]

Odor complaints sparking talk of new ordinances in Colorado

Colorado officials who have long since settled how to zone marijuana cultivation to address odor complaints are starting to turn their sights to the hemp industry. Local authorities in Boulder voted this week to limit hemp businesses to three within a 500-foot radius, an attempt to address smell complaints related to the college town’s five […]

European Commission weighs narcotic label for CBD, halts “novel food” applications

The European Commission has decided to halt “novel foods” applications to infuse edibles with CBD because it’s considering labeling the ingredient as related to narcotics. European Union regulators have said that cannabinoid extracts such as CBD are subject to a 1997 provision called the Novel Food Regulation, a set of guidelines for evaluating consumer safety […]

Elixinol’s new CEO defends CBD focus, offers leadership advice for economic downturn

The see-saw hemp industry has challenged all layers of the supply chain, from farmers looking to capitalize on a new crop to processors trying to find formulations that fit quickly changing rules. For international operators, those challenges have been even steeper. Australian hemp and CBD maker Elixinol Global has had a front-row seat to hemp […]

DPA Submits Amicus Brief Cosigned by AMA Supporting Attempt to Establish Supervised Consumption Site in Philadelphia 

Philadelphia, PA – Last week, the Drug Policy Alliance (DPA) submitted an amicus brief, which the American Medical Association (AMA) signed on to, in support of Safehouse being able to establish a supervised consumption site (SCS) in Philadelphia. The community-based organization is currently fending off an appeal by the federal government in the Third Circuit […]

1 134 135 136 137 138 305
Right Menu Icon